Fig. 1 · Structure
Documents & Downloads
BCI-215
DUSP-MKP Inhibitor
BCI-215 is a selective inhibitor of dual specificity MAPK phosphatases (DUSP-MKP). This compound exhibits potent cytotoxic activity against tumor cells, while sparing normal cells, making it a valuable tool for cancer research. BCI-215 is primarily used in studies focused on cancer cell signaling pathways and the role of DUSP-MKPs in tumor biology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1245792-67-9 |
| Applications | DUSP-MKP Inhibitor |
| Formula | C22H22BrNO |
| Molecular Weight | 396.32 |
| SMILES | O=C1/C(C(NC2CCCCC2)C3=C1C=CC(Br)=C3)=C/C4=CC=CC=C4 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.